IceCure Medical enters Exclusive Agreement in Poland

IceCure Medical Ltd., developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, announced that it has entered into an initial distribution agreement with Mobile SCANMED Systems SP. z o.o. to exclusively sell the Company’s ProSense™ Cryoablation System and disposables in Poland. Within twelve months of signing the initial distribution agreement, the parties expect to enter into a long-term exclusive distribution agreement.

“We are excited to announce the initial agreement with Mobile SCANMED Systems to distribute our ProSense Cryoablation System in Poland, expanding our reach in the European Union, where our system is currently approved under CE mark. This agreement builds on the distribution network we’ve established over the past year and is a part of our mission to bring this technology to all geographies,” commented Eyal Shamir, Chief Executive Officer of IceCure.


Our privacy policy
%d bloggers like this: